Abbott Laboratories (NYSE:ABT) PT Raised to $117.00 at Morgan Stanley
Abbott Laboratories (NYSE:ABT – Get Free Report) had its price target hoisted by investment analysts at Morgan Stanley from $107.00 to $117.00 in a report released on Thursday, Benzinga reports. The firm presently has an “equal weight” rating on the healthcare product maker’s stock. Morgan Stanley’s price objective indicates a potential downside of 2.00% from […]
19 Oct 09:49 · The Markets Daily